Regeneron Pharmaceuticals (REGN) EBT Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.15% |
| Dec 31, 2025 | 8.93% |
| Sep 30, 2025 | 18.10% |
| Jun 30, 2025 | -6.72% |
| Mar 31, 2025 | 29.16% |
| Dec 31, 2024 | -16.51% |
| Sep 30, 2024 | 34.41% |
| Jun 30, 2024 | 50.35% |
| Mar 31, 2024 | -18.33% |
| Dec 31, 2023 | -13.37% |
| Sep 30, 2023 | -26.43% |
| Jun 30, 2023 | 12.43% |
| Mar 31, 2023 | -19.14% |
| Dec 31, 2022 | -47.08% |
| Sep 30, 2022 | -16.89% |
| Jun 30, 2022 | -74.33% |
| Mar 31, 2022 | -15.32% |
| Dec 31, 2021 | 104.43% |
| Sep 30, 2021 | 81.97% |
| Jun 30, 2021 | 308.40% |
| Mar 31, 2021 | 87.41% |
| Dec 31, 2020 | 37.63% |
| Sep 30, 2020 | 29.90% |
| Jun 30, 2020 | 308.95% |
| Mar 31, 2020 | 22.43% |
| Dec 31, 2019 | 31.59% |
| Sep 30, 2019 | 20.85% |
| Jun 30, 2019 | -65.75% |
| Mar 31, 2019 | -6.71% |
| Dec 31, 2018 | 21.89% |
| Sep 30, 2018 | 12.43% |
| Jun 30, 2018 | 24.77% |
| Mar 31, 2018 | 35.42% |
| Dec 31, 2017 | 62.44% |
| Sep 30, 2017 | 54.59% |
| Jun 30, 2017 | 79.93% |
| Mar 31, 2017 | 30.94% |
| Dec 31, 2016 | 50.25% |
| Sep 30, 2016 | -6.97% |
| Jun 30, 2016 | -10.90% |
| Mar 31, 2016 | 19.39% |
| Dec 31, 2015 | 820.09% |
| Sep 30, 2015 | 116.30% |
| Jun 30, 2015 | 57.08% |
| Mar 31, 2015 | 52.87% |
| Dec 31, 2014 | -117.42% |
| Sep 30, 2014 | -19.43% |
| Jun 30, 2014 | 41.38% |
| Mar 31, 2014 | 27.54% |
| Dec 31, 2013 | 34.64% |
| Sep 30, 2013 | 17.87% |
| Jun 30, 2013 | 92.45% |
| Mar 31, 2013 | 1,117.33% |
| Dec 31, 2012 | 348.92% |
| Sep 30, 2012 | 409.80% |
| Jun 30, 2012 | 221.11% |
| Mar 31, 2012 | 126.68% |
| Dec 31, 2011 | -270.34% |
| Sep 30, 2011 | -82.44% |
| Jun 30, 2011 | -148.76% |
| Mar 31, 2011 | -43.05% |
| Dec 31, 2010 | 64.06% |
| Sep 30, 2010 | -3,237.44% |
| Jun 30, 2010 | -70.53% |